Biessels P T, Houwertjes M C, Agoston S, Horn A S
Eur J Pharmacol. 1987 Mar 17;135(2):155-9. doi: 10.1016/0014-2999(87)90607-8.
The neuromuscular, cardiovascular and central nervous system stimulating effects of 4-aminopyridine (4-AP), 2,4-diaminopyridine (2,4-DAP) and LF-14 were investigated in the monkey. All these compounds were shown to reverse the stable neuromuscular blockade produced by the intravenous infusion of pancuronium bromide. The doses producing 50% antagonism (ED50) of the pancuronium-induced neuromuscular block were 0.50, 0.54 and 0.71 mg/kg for LF-14, 2,4-DAP and 4-AP respectively. The compounds had only slight cardiovascular effects. In contrast to 4-AP, LF-14 and 2,4-DAP did not reduce the duration of ketamine/diazepam-induced anesthesia, suggesting minimal if any central nervous system effects of these two compounds.
在猴子身上研究了4-氨基吡啶(4-AP)、2,4-二氨基吡啶(2,4-DAP)和LF-14对神经肌肉、心血管和中枢神经系统的刺激作用。所有这些化合物都能逆转静脉输注潘库溴铵所产生的稳定神经肌肉阻滞。对于LF-14、2,4-DAP和4-AP,产生潘库溴铵诱导的神经肌肉阻滞50%拮抗作用(ED50)的剂量分别为0.50、0.54和0.71mg/kg。这些化合物只有轻微的心血管作用。与4-AP不同,LF-14和2,4-DAP不会缩短氯胺酮/地西泮诱导的麻醉持续时间,这表明这两种化合物对中枢神经系统的影响极小(如果有影响的话)。